Cochrane · systematic review · CD002253

Medical treatment for early fetal death (less than 24 weeks)

Lemmers, M, Verschoor, MAC, Kim, BV, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

Pregnancy and ChildbirthAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
14
current version
GRADE rated
13
No studies
1
Included studies
NR
No studies 1 · 7.1%Ungraded 0 · 0%Very low 2 · 14.3%Low 11 · 78.6%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Vaginal misoprostol compared to placebo for early fetal death (less than 24 weeks)

Population: early fetal death (less than 24 weeks)
7 questions
OutcomeEffectEvidenceStatus / GRADE
Complete miscarriage
Vaginal misoprostol vs placebo
RR 4.23 [3.01, 5.94]5 studies · 305 participantsLow
Downgraded: indirectness
Pelvic infection
Vaginal misoprostol vs placebo
no estimate extractedNRNo studies
Nausea
Vaginal misoprostol vs placebo
RR 1.38 [0.43, 4.4]2 studies · 88 participantsLow
Downgraded: risk of bias, imprecision, indirectness
Diarrhoea
Vaginal misoprostol vs placebo
RR 2.21 [0.35, 14.06]2 studies · 88 participantsLow
Downgraded: risk of bias, imprecision, indirectness
Blood loss: haemoglobin difference > 10 g/L
Vaginal misoprostol vs placebo
RR 1.25 [0.38, 4.12]1 study · 50 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Pain (opiate use)
Vaginal misoprostol vs placebo
RR 5 [0.25, 101.11]1 study · 84 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Woman’s satisfaction/acceptability of method
Vaginal misoprostol vs placebo
RR 1.17 [0.83, 1.64]1 study · 32 participantsLow
Downgraded: risk of bias, imprecision, indirectness

Vaginal misoprostol compared to surgical evacuation of uterus for early fetal death (less than 24 weeks)

Population: early fetal death (less than 24 weeks)
7 questions
OutcomeEffectEvidenceStatus / GRADE
Complete miscarriage
Vaginal misoprostol vs surgical evacuation of uterus
RR 0.4 [0.32, 0.5]6 studies · 943 participantsLow
Downgraded: risk of bias, imprecision
Pelvic infection
Vaginal misoprostol vs surgical evacuation of uterus
RR 0.73 [0.39, 1.37]1 study · 618 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Nausea
Vaginal misoprostol vs surgical evacuation of uterus
RR 21.85 [1.31, 364.37]1 study · 154 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Diarrhoea
Vaginal misoprostol vs surgical evacuation of uterus
RR 40.85 [2.52, 662.57]1 study · 154 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Blood loss: post‐treatment haematocrit (%)
Vaginal misoprostol vs surgical evacuation of uterus
no estimate extracted1 study · 50 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Pain relief
Vaginal misoprostol vs surgical evacuation of uterus
RR 1.421 study · 154 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Woman’s satisfaction/acceptability of method
Vaginal misoprostol vs surgical evacuation of uterus
RR 0.67 [0.4, 1.11]1 study · 45 participantsLow
Downgraded: risk of bias, imprecision, inconsistency